I'm interested in this position https://orpheogroup.com/stmap_21wizxfu.html?flutamide.trental.levitra.cephalexin varenicline side effects usmle The first investment by the fund, which will be based in Cambridge, Massachusetts, will be in SetPoint Medical, a California company which GSK says "is considered a trailblazer in creating implantable devices to treat inflammatory diseases". SetPoint also noted that it has raised $27 million in financing from current investors along with new backers Boston Scientific,ツCovidien Ventures and the new GSK fund.